clenbuterol has been researched along with Cerebral Ischemia in 6 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Combinations of memantine with clenbuterol extend the respective therapeutic window and provide synergistic cerebroprotective effects after stroke." | 7.72 | Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. ( Culmsee, C; Junker, V; Kremers, W; Krieglstein, J; Plesnila, N; Thal, S, 2004) |
"Combinations of memantine with clenbuterol extend the respective therapeutic window and provide synergistic cerebroprotective effects after stroke." | 3.72 | Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. ( Culmsee, C; Junker, V; Kremers, W; Krieglstein, J; Plesnila, N; Thal, S, 2004) |
"In a model of focal cerebral ischemia in mice the cerebroprotective effect of clenbuterol (0." | 1.31 | Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. ( Becker, A; Culmsee, C; Hühne, R; Junker, V; Krieglstein, J; Ravati, A; Zembatov, M, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Esperón, C | 1 |
Hervás-García, JV | 1 |
Jiménez-González, M | 1 |
Pérez de la Ossa-Herrero, N | 1 |
Gomis-Cortina, M | 1 |
Dorado-Bouix, L | 1 |
López-Cancio Martinez, E | 1 |
Castaño-Duque, CH | 1 |
Millán-Torné, M | 1 |
Dávalos, A | 1 |
Rami, A | 2 |
Volkmann, T | 1 |
Agarwal, R | 1 |
Schoninger, S | 1 |
Nürnberger, F | 1 |
Saido, TC | 1 |
Winckler, J | 1 |
Culmsee, C | 3 |
Junker, V | 3 |
Kremers, W | 2 |
Thal, S | 2 |
Plesnila, N | 2 |
Krieglstein, J | 4 |
Maier, S | 1 |
Schneider, HJ | 1 |
Semkova, I | 1 |
Schilling, M | 1 |
Henrich-Noack, P | 1 |
Becker, A | 1 |
Hühne, R | 1 |
Zembatov, M | 1 |
Ravati, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pilot Study of Memantine for Enhanced Stroke Recovery[NCT02144584] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2014-01-31 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for clenbuterol and Cerebral Ischemia
Article | Year |
---|---|
[Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature].
Topics: Adult; Alcoholism; Anabolic Agents; Brain Ischemia; Cerebral Angiography; Clenbuterol; Doping in Spo | 2013 |
5 other studies available for clenbuterol and Cerebral Ischemia
Article | Year |
---|---|
beta2-Adrenergic receptor responsiveness of the calpain-calpastatin system and attenuation of neuronal death in rat hippocampus after transient global ischemia.
Topics: Animals; Apoptosis; Blotting, Western; Brain Ischemia; Calcium-Binding Proteins; Calpain; Clenbutero | 2003 |
Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Brain Ischemia; Cells, Cultured; Clenbuterol; Disease Models, Ani | 2004 |
Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia.
Topics: Adrenergic beta-Agonists; Animals; Astrocytes; Blood Glucose; Blood Pressure; Brain Ischemia; Cells, | 2007 |
Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.
Topics: Animals; Animals, Newborn; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Clenbuterol; Glutamic A | 1996 |
Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Astrocytes; Brain Ischemia; Cell Dea | 2002 |